Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Testicular germ cell tumor
Results 1-25 of 27 for your search:
Start Over
Combination Chemotherapy and Fixed or Flexible Administration of Filgrastim in Treating Younger Patients With Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 1 to 25
Trial IDs: 2013-062, NCI-2013-02001, NCT01987596
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Status: Active
Phase: Phase III
Type: Treatment
Age: 14 and over
Trial IDs: A031102, NCI-2014-01696, 1407-GUCG, 2014-003930-17, PA031102_A01PAMDREVW01, NCT02375204
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Gemcitabine Hydrochloride, Oxaliplatin, and Paclitaxel in Treating Patients With Refractory Germ Cell Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: 4T-03-1, NCI-2011-01350, NCT00183820
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 10 to 69
Trial IDs: MT2005-21, NCI-2010-01700, 2006LS032, UMN-2006LS032, UMN-MT2005-21, UMN-0608M90586, NCT00432094
High-Dose Chemotherapy, Bevacizumab and Stem Cell Transplant in Treating Patients with Recurrent Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 12 to 65
Trial IDs: 2008-0378, NCI-2011-01631, NCT00936936
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Status: Active
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, 1211010041, 1211010041R001, HOG QL12-153, NCT01736917
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: IUCRO-0403, NCI-2013-00510, 1301010501, NCT01808534
Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: PM1183-B-005-14, NCI-2015-01172, NCT02454972
Retroperitoneal Lymph Node Dissection in Treating Patients with Stage I-IIA Testicular Seminoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 4T-14-1, NCI-2015-01177, HS-15-00246, NCT02537548
Pembrolizumab in Treating Patients with Rare Solid Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0948, NCI-2016-00545, NCT02721732
Veliparib, Paclitaxel, and Carboplatin in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 8808, NCI-2011-02500, CDR0000700997, UPCI 10-115, NCT01366144
Donor Hematopoietic Stem Cell Transplant in Treating Young Patients with Relapsed or Refractory Solid Tumors or Lymphomas
Status: Active
Phase: Phase I
Type: Treatment
Age: 2 to 21
Trial IDs: RADIANT, NCI-2012-00588, NCT01625351
Donor Lymphocyte Infusion in Treating Patients Previously Treated with Donor Stem Cell Transplant
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00003975, NCI-2013-00567, NCT01627275
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PM60184-A-003-14, NCI-2015-01510, 2014-002943-16, NCT02533674
Collecting and Storing Tissue From Young Patients With Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 21 and under
Trial IDs: ABTR04B1, NCI-2009-00326, CDR0000478867, COG-ABTR04B1, NCT00898755
Informed Consent to Enroll Younger Patients with Newly Diagnosed Cancer in the Childhood Cancer Research Network
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Age: 18 and under
Trial IDs: ACCRN07, NCI-2009-00331, CDR0000069496, 10-C-0111, NCT01117168
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 19 and under
Trial IDs: AEPI10N1, NCI-2011-03464, CDR0000711070, COG-AEPI10N1, NCT01434355
Magnetic Resonance Imaging in Planning Radiation Therapy in Patients with Liver, Brain, Head and Neck, or Pelvic Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: UMCC 2012.113, NCI-2012-02750, HUM00068061, NCT02045381
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Etiologic Study of Familial Testicular Cancer
Status: Active
Phase: No phase specified
Type: Genetics, Natural history/Epidemiology
Age: 12 and over
Trial IDs: 02-C-0178, NCI-2013-02030, NCT00039598, NCT00034424
Molecular-Guided Therapy for Childhood Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 12 months to 21 years
Trial IDs: NMTRC009, NCI-2014-02270, NCT02162732
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Status: Active
Phase: No phase specified
Type: Health services research, Supportive care
Age: 18 to 39
Trial IDs: 9161, NCI-2014-01325, NCT02192333
NanoFOD and External Beam Radiation Therapy in Monitoring Radiation Dose in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: Pro00061601, NCI-2015-02179, NCT02407977
Start Over